Works matching IS 03618609 AND DT 2015 AND VI 90 AND IP 1


Results: 25
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 1, p. 42, doi. 10.1002/ajh.23868
    By:
    • Orlowski, Robert Z.;
    • Gercheva, Liana;
    • Williams, Cathy;
    • Sutherland, Heather;
    • Robak, Tadeusz;
    • Masszi, Tamás;
    • Goranova-Marinova, Vesselina;
    • Dimopoulos, Meletios A.;
    • Cavenagh, James D.;
    • Špička, Ivan;
    • Maiolino, Angelo;
    • Suvorov, Alexander;
    • Bladé, Joan;
    • Samoylova, Olga;
    • Puchalski, Thomas A.;
    • Reddy, Manjula;
    • Bandekar, Rajesh;
    • van de Velde, Helgi;
    • Xie, Hong;
    • Rossi, Jean-Franςois
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    25

    The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 1, p. 56, doi. 10.1002/ajh.23872
    By:
    • Rossi, Giuseppe;
    • Marcheselli, Luigi;
    • Dondi, Alessandra;
    • Bottelli, Chiara;
    • Tucci, Alessandra;
    • Luminari, Stefano;
    • Arcaini, Luca;
    • Merli, Michele;
    • Pulsoni, Alessandro;
    • Boccomini, Carola;
    • Puccini, Benedetta;
    • Micheletti, Moira;
    • Martinelli, Giovanni;
    • Rossi, Andrea;
    • Zilioli, Vittorio Ruggero;
    • Bozzoli, Valentina;
    • Balzarotti, Monica;
    • Bolis, Silvia;
    • Cabras, Maria Giuseppina;
    • Federico, Massimo
    Publication type:
    Article